Close Menu
    What's Hot

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    Khaleej PressKhaleej Press
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • More
      • Sports
      • Technology
      • Travel
    Khaleej PressKhaleej Press
    Home » Nationwide shock as CVS and Walgreens begin abortion pill sales
    Health

    Nationwide shock as CVS and Walgreens begin abortion pill sales

    March 2, 2024
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Two of the largest pharmacy chains in the United States, CVS and Walgreens, have announced plans to make the abortion pill, mifepristone, available for sale across the country. This decision marks a significant shift in reproductive healthcare accessibility. Both CVS and Walgreens disclosed on Friday that they have obtained Risk Evaluation and Mitigation Strategy (REMS) certifications from the Food and Drug Administration (FDA). These certifications are crucial prerequisites for pharmacies and prescribers to dispense mifepristone, emphasizing safety protocols and risk assessment.

    Nationwide shock as CVS and Walgreens begin abortion pill sales

    The REMS program, mandated by the FDA for drugs with substantial safety concerns, aims to ensure that the benefits of the medication outweigh potential risks. However, critics argue that the requirement for mifepristone under REMS lacks scientific basis and restricts access to the drug, fueling ongoing debates surrounding reproductive rights. In response to inquiries, CVS issued a statement to The Hill, confirming their readiness to dispense mifepristone.

    While currently not available in any of their pharmacies, CVS plans to initiate the distribution process soon, starting with states where legal regulations permit. The pharmacy giant aims for a gradual expansion across states, ensuring compliance with local laws and regulations. Similarly, a spokesperson for Walgreens affirmed the completion of the FDA certification process for mifepristone dispensation. They outlined a phased rollout strategy, initially targeting select locations in states such as New York, Pennsylvania, Massachusetts, California, and Illinois.

    Walgreens also indicated plans to offer the generic form of the pill in the future, enhancing affordability and accessibility for patients. US President, Joe Biden hailed the announcement, highlighting its significance in expanding healthcare options for women. He emphasized the importance of ensuring access to medication abortion through certified pharmacy chains, particularly amid ongoing challenges to reproductive rights nationwide.

    However, mifepristone’s FDA approval has been embroiled in legal disputes, with a federal lawsuit challenging its status as an abortifacient. While a panel of judges upheld the approval, they reversed federal measures aimed at broadening access to the drug. The Department of Justice has petitioned the Supreme Court to reconsider this decision, setting the stage for a pivotal legal showdown.

    The Supreme Court has scheduled arguments on the case, with a hearing slated for March 26, raising the stakes for reproductive rights advocates and healthcare providers alike. This development underscores the intersection of healthcare, legal, and political realms, shaping the landscape of reproductive rights in the United States. As the nation awaits further legal proceedings, the availability of mifepristone through major pharmacy chains represents a significant milestone in ensuring equitable access to reproductive healthcare services.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    WHO reports 67 yellow fever cases in nine African countries

    November 7, 2026

    Bangladesh dengue deaths reach 418 after deadliest month of 2026

    November 2, 2026
    Latest News

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Petrol price jump lifts South Africa inflation as SARB weighs rates

    November 18, 2026
    © 2023 Khaleej Press | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.